"Publishing their work in the journal Nature Communications, Dr. Benedikt Zott and his colleagues at TUM have taken a bold new approach to Alzheimer’s treatment. Instead of targeting the plaques that form later in the disease, they’ve set their sights on the Aβ monomers themselves. Their weapon of choice? A specially designed protein called an anticalin."

https://studyfinds.org/stop-and-reverse-alzheimers/